Biochemistry

2008 Submissions

[5] viXra:2008.0153 [pdf] submitted on 2020-08-20 19:49:33

The Origin of Life on Earth, the Panspermia Hypothesis and Cosmological DNA Synthesis.

Authors: Bezverkhniy Volodymyr Dmytrovych, Bezverkhniy Vitaliy Volodymyrovich
Comments: 12 Pages.

The process of the rapid origin of life on Earth is analyzed, taking into account the evolution of our Sun (the beginning of thermonuclear reactions). Given the knowledge about DNA, viruses and the structure of bacteria, it is concluded that the origin of life on Earth was initiated from the outside. Further, using space chemistry, it is shown that spontaneous assembly of DNA/RNA molecules can occur on particles of interstellar and intergalactic dust. Therefore, when favorable conditions are created on the planet, the emergence of life begins rapidly, since the initiators of life are already available from cosmic dust (RNA and DNA molecules).
Category: Biochemistry

[4] viXra:2008.0135 [pdf] submitted on 2020-08-18 18:06:57

The Infectious Vaccines Against SARS-CoV-2 May Already Exist

Authors: Ding Jian
Comments: 5 Pages. I firmly believe that a single spark can start great creative conflagrations.

In allusion to the COVID-19 epidemic situation, the current key point to win the decisive victory is on how to improve the antibody prevalence, so as to achieve herd immunity and eventually eliminate the epidemic situation. Therefore, it is strongly recommended that an authoritative experimental conclusion should be given on whether the recovered patients with COVID-19 are infectivity or not. That is to say, those susceptible people who have not yet had the antibodies should be tested, in order to verify whether they would produce antibodies after close contact with the recovered patients who have had the antibodies. Of course, this is a feasible experiment. The implication that there should be a type of infectious vaccines against SARS-CoV-2, which is always around us and well within reach. In addition, it is pointed out that the state of balance where the viruses and the human immune system are opposed and can coexist is the environment they face for survival and proliferation, while the infectivity is the necessary condition. It is under such environment that the progenies of those original viruses would be just possible to be improved by human immune system, thereby evolve into the main part of the IgG antibodies. Since asymptomatic infected persons are now confirmed to transmit the viruses, so it is inferred that the Infectious Attenuated Live Vaccine against SARS-CoV-2 must be there too.
Category: Biochemistry

[3] viXra:2008.0133 [pdf] submitted on 2020-08-18 18:18:36

具有传染性的新冠病毒疫苗已经存在 (The Infectious Vaccines a Gainst Sars Cov 2 Already Exist)

Authors: Ding Jian
Comments: Pages.

针 对 COVID 19 疫情，当前决胜的关键，在于如何提高抗体流行率，以达到群体免疫，最终解除疫情这个目的。因此强烈建议，针对 COVID 19 的康复患者是否具有传染性，给出一个权威的实验结论。也就是说，应该检测那些尚未具有抗体的易受感染者，以验证他们在与这些已具有抗体的康复患者密切接触之后，是否会产生抗体？当然 这是一个可行的实验。 这意味着，应该有一种具有传染性的新冠病毒（ SARS CoV 2 ）疫苗一直 存在于我们身边，而且是唾手可得。 此外还指出，病毒与人体免疫系统对立且能共处的平衡状态，是它们生存和增殖所面临的环境，而传染性是必要条件。 正是在这样的环境下，那些原始病毒的后代才有可能得到人体免疫系统的改良，从而进化成 IgG 抗体的主体。 鉴于目前已确认无症状感染者可以传播病毒，于是推断，具有传染性的新冠病毒减毒活疫苗也一定存在。 (In allusion to the COVID-19 epidemic situation, the current key point to win the decisive victory is on how to improve the antibody prevalence, so as to achieve herd immunity and eventually eliminate the epidemic situation. Therefore, it is strongly recommended that an authoritative experimental conclusion should be given on whether the recovered patients with COVID-19 are infectivity or not. That is to say, those susceptible people who have not yet had the antibodies should be tested, in order to verify whether they would produce antibodies after close contact with the recovered patients who have had the antibodies. Of course, this is a feasible experiment. The implication that there should be a type of infectious vaccines against SARS-CoV-2, which is always around us and well within reach. In addition, it is pointed out that the state of balance where the viruses and the human immune system are opposed and can coexist is the environment they face for survival and proliferation, while the infectivity is the necessary condition. It is under such environment that the progenies of those original viruses would be just possible to be improved by human immune system, thereby evolve into the main part of the IgG antibodies. Since asymptomatic infected persons are now confirmed to transmit the viruses, so it is inferred that the Infectious Attenuated Live Vaccine against SARS-CoV-2 must be there too. )
Category: Biochemistry

[2] viXra:2008.0102 [pdf] submitted on 2020-08-14 09:59:13

An Examination of the Scientific Evidence for the Existence of the SARS-Cov-2 Virus and Its Relation to COVID-19

Authors: Ryan C. Matters
Comments: 8 Pages.

Following increased respiratory illness in Wuhan, China, a novel coronavirus was isolated, and named ‘SARS-Cov-2’. This was then determined to be the cause of the respiratory illness now termed ‘COVID-19’. This paper argues that there is no evidence in the scientific literature to suggest that the SARS-Cov-2 virus exists, let alone causes illness. The fact remains that SARS-Cov-2 has never been purified, despite this being the agreed upon procedure for proving the existence of a virus. This paper argues that a virus is not the cause of COVID-19 and therefore alternate possible causes must be examined.
Category: Biochemistry

[1] viXra:2008.0070 [pdf] submitted on 2020-08-11 10:10:49

Enteric Bacteria, Simple Introduction with Numerical Optical Sectioning

Authors: J.W.Stanford, R. A. Bartels, C. S. Menoni
Comments: 20 Pages.

Human gastrointestinal microbiota, also known as gut ora or gut mi- crobiota, are the microorganisms (generally bacteria and archaea), that live in the digestive tracts of humans. Many non-human animals, in- cluding insects, are hosts to numerous microorganisms that reside in the gastrointestinal tract as well. The human gastrointestinal metagenome is the aggregate of all the genomes of gut microbiota. The gut is one niche that human microbiota inhabit.
Category: Biochemistry